Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA 5/22/2022 ATHEROSCLEROSIS OF AORTA I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 8/22/2022 ATHEROSCLEROSIS OF AORTA I95.9 HYPOTENSION 11/26/2022 ATHEROSCLEROSIS OF AORTA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 ATHEROSCLEROSIS OF AORTA G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA 5/22/2022 FALL RISK I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 8/22/2022 FALL RISK I95.9 HYPOTENSION 11/26/2022 FALL RISK J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 FALL RISK G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA 5/22/2022 SYNCOPE I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 8/22/2022 SYNCOPE I95.9 HYPOTENSION 11/26/2022 SYNCOPE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 SYNCOPE G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA 5/22/2022 CANCER METASTATIC TO SKIN I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 8/22/2022 CANCER METASTATIC TO SKIN I95.9 HYPOTENSION 11/26/2022 CANCER METASTATIC TO SKIN J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 CANCER METASTATIC TO SKIN G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA 5/22/2022 FAILURE TO THRIVE SYNDROME, ADULT I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 8/22/2022 FAILURE TO THRIVE SYNDROME, ADULT I95.9 HYPOTENSION 11/26/2022 FAILURE TO THRIVE SYNDROME, ADULT J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 FAILURE TO THRIVE SYNDROME, ADULT G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA 5/22/2022 ATHEROSCLEROSIS OF AORTA I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 8/22/2022 ATHEROSCLEROSIS OF AORTA I95.9 HYPOTENSION 11/26/2022 ATHEROSCLEROSIS OF AORTA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 ATHEROSCLEROSIS OF AORTA G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA 5/22/2022 ALTERED MENTAL STATUS, UNSPECIFIED I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 8/22/2022 ALTERED MENTAL STATUS, UNSPECIFIED I95.9 HYPOTENSION 11/26/2022 ALTERED MENTAL STATUS, UNSPECIFIED J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 ALTERED MENTAL STATUS, UNSPECIFIED G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA 5/22/2022 CANCER METASTATIC TO AXILLARY LN I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 8/22/2022 CANCER METASTATIC TO AXILLARY LN I95.9 HYPOTENSION 11/26/2022 CANCER METASTATIC TO AXILLARY LN J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 CANCER METASTATIC TO AXILLARY LN G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA 5/22/2022 PALLIATIVE CARE I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 8/22/2022 PALLIATIVE CARE I95.9 HYPOTENSION 11/26/2022 PALLIATIVE CARE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 PALLIATIVE CARE G62.0 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA 5/22/2022 ALTERED MENTAL STATUS, UNSPECIFIED I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 8/22/2022 ALTERED MENTAL STATUS, UNSPECIFIED I95.9 HYPOTENSION 11/26/2022 ALTERED MENTAL STATUS, UNSPECIFIED J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/26/2022 ALTERED MENTAL STATUS, UNSPECIFIED